Today: 20 May 2026
Apple stock price ends week higher as Dow hits 50,000; jobs and CPI loom next
7 February 2026
2 mins read

Apple stock price ends week higher as Dow hits 50,000; jobs and CPI loom next

New York, Feb 7, 2026, 08:51 EST — The market has wrapped up for the day.

  • Apple ended Friday up 0.8%, though the stock edged lower once after-hours trading kicked in
  • Chipmakers rallied, pushing Wall Street higher, while Amazon slipped on its capital spending forecast.
  • Investors are now waiting on delayed U.S. jobs numbers set for Feb. 11, followed by CPI data due Feb. 13.

Apple finished Friday with a gain, up 0.8% to close at $278.12. After the bell, shares slipped back 0.3% to $277.25 as the market looked ahead to Monday’s open.

That wrapped up a turbulent week among megacap tech, with traders wrestling over whether fresh jitters about artificial intelligence spending are just a bump in the road or the start of something more persistent.

This puts Apple in a unique spot: it’s not only a Dow heavyweight, but also a growth-stock bellwether. And with the next batch of U.S. data looming, the pressure’s on as investors brace for a possible reset in interest-rate cut expectations.

Stocks in the U.S. rallied Friday, the S&P 500 gaining 1.97% and the Nasdaq climbing 2.18%, led higher by chipmaker strength. Shares of Amazon slid 5.6% after the company said it expects capital expenditures to shoot up by more than 50%—money set aside for equipment and data centers—as competition in AI heats up.

“This trade has been volatile,” said Ross Mayfield, investment strategy analyst at Baird. He pointed to “real demand for AI products” that’s been able to “put a ‘floor’ under the group” following selloffs. Reuters

The Dow finished above 50,000 for the first time, hitting a new milestone as investors appeared to rotate out of a narrow group of tech leaders. “What’s driven it recently has been the broadening,” said Chuck Carlson, chief executive at Horizon Investment Services. Reuters

Apple shares managed a modest, steady climb this week, rising roughly 3% from Monday’s close, Investing.com data shows.

After a stellar holiday stretch, Apple remains on a tear. On Jan. 29, the company reported revenue of $143.8 billion and earnings per share at $2.84. CEO Tim Cook described iPhone demand as “unprecedented.” Apple

Still, Apple is warning about supply snags that might impact the near term. Following the results, Cook told analysts that certain processor shortages were hitting iPhone output, adding, “it’s difficult to predict when supply and demand will balance,” according to Reuters. Reuters

One risk that hasn’t gone away: another jump in rates, or a pullback from crowded “AI trade” bets, could weigh on tech valuations—Apple included. Right now, the company’s forecast depends on what it pays for parts and whether it can get them. Apple, in its latest filing, repeated the usual warning: future statements come with “risks and uncertainties,” and actual results might look very different. SEC

Apple has set its upcoming dividend at $0.26 per share, according to the company’s investor relations page. Shareholders of record as of Feb. 9 will get paid on Feb. 12.

Apple’s annual meeting lands on Feb. 24, and this year it’s going virtual, the company said.

Looking ahead, macro drivers take center stage. The U.S. January employment report, postponed by the recent government shutdown, lands on Wednesday, Feb. 11. Two days later, January CPI numbers hit on Friday, Feb. 13.

The Bureau of Labor Statistics has the CPI release scheduled for 8:30 a.m. on Feb. 13—a number that could jolt Treasury yields and ripple through rate-sensitive names like Apple.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen
Previous Story

Exxon Mobil stock price just tagged a new high — what could move XOM when markets reopen

Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week
Next Story

Strategy (MSTR) stock price whipsaws after $12.4 billion loss as bitcoin steadies — what to watch next week

Go toTop